IRIDEX Corporation (NASDAQ:IRIX) is set to release its earnings data after the market closes on Thursday, November 2nd. Analysts expect IRIDEX Corporation to post earnings of ($0.28) per share for the quarter.

IRIDEX Corporation (NASDAQ:IRIX) last announced its quarterly earnings data on Thursday, August 3rd. The medical equipment provider reported ($0.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.18) by ($0.06). The business had revenue of $10.00 million during the quarter, compared to analyst estimates of $10.48 million. IRIDEX Corporation had a negative return on equity of 16.87% and a negative net margin of 37.62%. On average, analysts expect IRIDEX Corporation to post $-0.72 EPS for the current fiscal year and $-0.64 EPS for the next fiscal year.

IRIDEX Corporation (NASDAQ IRIX) opened at 9.05 on Thursday. IRIDEX Corporation has a 52 week low of $7.58 and a 52 week high of $16.39. The stock has a 50 day moving average of $9.49 and a 200 day moving average of $9.43. The firm’s market cap is $104.68 million.

Separately, Zacks Investment Research raised IRIDEX Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, October 4th.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/10/26/iridex-corporation-irix-scheduled-to-post-earnings-on-thursday-2.html.

About IRIDEX Corporation

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD).

Earnings History for IRIDEX Corporation (NASDAQ:IRIX)

Receive News & Ratings for IRIDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Corporation and related companies with MarketBeat.com's FREE daily email newsletter.